← Eichor
Study identifier: NCT07305519 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:

Condition: Preterm Labor  ·  Sponsor: University of Roma La Sapienza

PhaseNA
Planned participants150
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of the study is to assess the effect of a combination of Magnesium, Palmitoylethanolamide, high-molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in women at risk of preterm birth (PTB).

This description comes directly from the study's public registry record.

Talk to the study team

Giuseppe RIZZO, Professor  ·  +393386973001  ·  giuseppe.rizzo@uniroma1.it

Always discuss trial participation with your own doctor first.

Locations (1)

Policlinico Umberto IRome, RM, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07305519